Cargando…

SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review

Sodium-glucose transport protein 2 inhibitors, commonly referred to as SGLT2i, are a group of prescription pharmaceuticals that are approved by the United States Food and Drug Administration for use with diet and exercise to lower blood glucose in adults with type 2 diabetes. Diabetes is a well-reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kansara, Abhishek, Mubeen, Faiza, Shakil, Jawairia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Houston Methodist DeBakey Heart & Vascular Center 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461689/
https://www.ncbi.nlm.nih.gov/pubmed/36132575
http://dx.doi.org/10.14797/mdcvj.1120